A. Vartanian

A microRNA Link to Glioblastoma Heterogeneity

G. Zadeh, S. Singh, A. Vartanian, 2012, Cancers.

GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.

Gelareh Zadeh, Shahrzad Jalali, K. Aldape, 2014, Neuro-oncology.

TM-02IDENTIFICATION OF THE AZOLE CLASS OF ANTIFUNGALS AS POTENT INHIBITORS OF HEXOKINASE II MEDIATED TUMOUR METABOLISM IN GLIOBLASTOMA.

K. Aldape, G. Zadeh, S. Agnihotri, 2014 .

Role of hexokinase 2 (HK2) in modulating tumor metabolism and response to therapy in glioblastoma

A. Vartanian, K. Burrell, S. Jalali, 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

Lauren M Sanders, Lauren M. Sanders, M. Moran, 2022, Nature Cancer.

Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

Lauren M Sanders, Lauren M. Sanders, M. Moran, 2022, Nature Cancer.

Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma

K. Aldape, G. Zadeh, S. Agnihotri, 2016, Oncotarget.

Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells

K. Aldape, G. Zadeh, S. Agnihotri, 2018, Clinical Cancer Research.

Revered today, loved tomorrow: Expert creativity ratings predict popularity of architects’ works 50 years later.

P. Silvia, R. Beaty, Emily C. Nusbaum, 2017 .